SpectrumDNA, Inc.
SPXA
$0.00
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 9.94% | 36.95% | 51.50% | -5.61% | -1.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.94% | 36.95% | 51.50% | -5.61% | -1.87% |
| Cost of Revenue | -75.00% | -94.70% | -97.60% | -96.72% | -95.83% |
| Gross Profit | 193.33% | 70.19% | 24.25% | -39.87% | -18.66% |
| SG&A Expenses | -50.17% | -52.37% | -51.39% | -40.90% | -32.94% |
| Depreciation & Amortization | -28.57% | -2.22% | 27.50% | 24.71% | 28.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -49.45% | -52.85% | -52.21% | -42.80% | -36.01% |
| Operating Income | 57.07% | 57.79% | 55.46% | 41.68% | 34.59% |
| Income Before Tax | 223.55% | 190.12% | 171.67% | 156.26% | 29.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 223.55% | 190.12% | 171.67% | 156.26% | 29.76% |
| Earnings from Discontinued Operations | 35.39% | -153.38% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 180.11% | 155.71% | 150.75% | 135.23% | 8.67% |
| EBIT | 57.07% | 57.79% | 55.46% | 41.68% | 34.59% |
| EBITDA | 57.21% | 58.03% | 55.81% | 41.97% | 34.73% |
| EPS Basic | 171.12% | 145.45% | 138.32% | 123.46% | 27.33% |
| Normalized Basic EPS | 208.33% | 173.36% | 155.25% | 139.42% | 43.04% |
| EPS Diluted | 171.12% | 145.45% | 138.32% | 123.46% | 27.33% |
| Normalized Diluted EPS | 208.33% | 173.36% | 155.25% | 139.42% | 43.04% |
| Average Basic Shares Outstanding | 10.05% | 19.33% | 30.52% | 38.04% | 29.42% |
| Average Diluted Shares Outstanding | 10.05% | 19.33% | 30.52% | 38.04% | 29.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |